Aster DM Healthcare Limited (BOM:540975)
India
· Delayed Price · Currency is INR | Market Cap | 364.51B |
| Revenue (ttm) | 44.61B |
| Net Income (ttm) | 3.27B |
| Shares Out | n/a |
| EPS (ttm) | 6.40 |
| PE Ratio | 111.47 |
| Forward PE | 41.47 |
| Dividend | 4.00 (0.57%) |
| Ex-Dividend Date | Apr 2, 2026 |
| Volume | 766,658 |
| Average Volume | 166,807 |
| Open | 710.20 |
| Previous Close | 705.40 |
| Day's Range | 708.00 - 724.05 |
| 52-Week Range | 497.15 - 732.00 |
| Beta | n/a |
| RSI | 60.17 |
| Earnings Date | Apr 30, 2026 |
About Aster DM Healthcare
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India. [Read more]
Financial Performance
In fiscal year 2025, Aster DM Healthcare's revenue was 41.38 billion, an increase of 11.88% compared to the previous year's 36.99 billion. Earnings were 53.78 billion, an increase of 4059.83%.
Financial StatementsNews
Stocks to buy: What's the outlook for Nifty for March 30-April 3 week? Check list of top stock recommendations
Stock market recommendations: Aster DM Healthcare, and Karur Vysya Bank are the top stocks that have been recommended by Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities for the ...
Aster DM Healthcare announces Rs 3 interim dividend per share for FY 2025-26
Aster DM Healthcare has declared an interim dividend of ₹3 per equity share for the financial year 2025-26. The announcement was made during the Board of Directors meeting held on…
Aster DM Healthcare secures 96.68% shareholder approval for merger with QCIL
Aster DM Healthcare Limited has received an overwhelming 96.68% voting approval from its shareholders for the proposed merger with Quality Care India Limited (QCIL). The merger is set to create…
Aster DM Healthcare secures 100% approval for amalgamation scheme from creditors
Aster DM Healthcare's unsecured trade creditors have overwhelmingly approved the Scheme of Amalgamation with Quality Care India Limited. The resolution received 100% votes in favour from the creditors...
Aster DM Healthcare appoints Dr. Azad Moopen as Executive Director
Aster DM Healthcare has announced the appointment of Dr. Azad Moopen as Executive Director, effective from 15 April 2026 to 28 May 2028. This decision was made during the company's…
Pharma sector stocks today, Feb 11: Aster DM Healthcare up 2.39%, Jeena Sikho down 2.75%, Concord Biotech falls 2.10%
The Indian pharmaceutical sector showed mixed performance on February 11, 2026, as of around 10:20 AM IST. The Nifty Pharma...
Aster DM Healthcare Ltd (BOM:540975) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...
Aster DM Healthcare Ltd (BOM:540975) Q3 2026 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansion Plans
Q3 2026 Aster DM Healthcare Ltd Earnings Call Transcript
Q3 2026 Aster DM Healthcare Ltd Earnings Call Transcript
Aster DM Healthcare Transcript: Q3 25/26
Combined Aster and Quality Care delivered strong double-digit revenue and EBITDA growth, with robust performance in Kerala and significant expansion plans underway. Margin pressures from new capacity and talent investments are expected to be offset by synergies post-merger, targeting 24%-25% EBITDA margins in three years.
Aster DM Healthcare Ltd (BOM:540975) Q2 2026 Earnings Call Highlights: Robust Growth and ...
Aster DM Healthcare Ltd (BOM:540975) Q2 2026 Earnings Call Highlights: Robust Growth and Strategic Expansion
Q2 2026 Aster DM Healthcare Ltd Earnings Call Transcript
Q2 2026 Aster DM Healthcare Ltd Earnings Call Transcript
Aster DM Healthcare Transcript: Q2 25/26
Q2 FY 2026 saw robust revenue and margin growth, led by Kerala's recovery and strong performance across clusters. The merger with QCL is progressing, with significant expansion and synergy plans set to drive future growth and profitability.
Stocks hitting 52-week highs today: Aster DM Healthcare, Ather Energy, and RBL Bank among top movers
Several stocks touched fresh 52-week highs in today’s session, reflecting positive market sentiment across sectors. Aster DM Healthcare, Ather Energy,...
Aster DM Healthcare CEO of Digital Health Dr. Harsha Rajaram resigns
Aster DM Healthcare has announced that Dr. Harsha Rajaram, CEO of Aster Digital Health and a senior management leader at the company, has resigned from his position, effective from the close of busine...
Aster DM Healthcare share price: HSBC maintains buy, sees 6% upside as merger with QCIL progresses
HSBC has reiterated its buy rating on Aster DM Healthcare with a target price of ₹680 per share. At the current market price of ₹641.10, the target implies an upside of about 6 percent. The brokerage ...
Aster DM Healthcare Transcript: Q1 25/26
Q1 FY 2026 delivered 8% revenue and 21% EBITDA growth, with strong recovery in Kerala and robust expansion plans. The QCIL merger is progressing, creating a 10,350+ bed network, while ARPOB and margins continue to improve across clusters.
Aster DM Healthcare acquires additional 13% stake in DRCM for Rs 63.01 crore, raises holding to 70.49%
Aster DM Healthcare has announced key strategic developments aimed at expanding its footprint in India. In a meeting held on July 30, 2025, the company’s Investment and Finance Committee approved two ...
Aster DM Healthcare lines up Rs 1,900 crore capex to expand presence
Bengaluru: Aster DM Healthcare has lined up Rs 1,900 crore to expand its hospital network across India. This strategic expansion aims to increase its .
Aster DM Healthcare Transcript: Q4 24/25
FY 2025 saw 12% revenue growth, 30% EBITDA growth, and margin expansion to 19.5%, driven by operational efficiencies and strategic exits from loss-making segments. The merger with QCIL will create a top-three hospital network, with robust expansion and digital initiatives underway.
Aster DM Healthcare shares drop over 3% following Q4 FY25 Results
Shares of Aster DM Healthcare Ltd fell over 3.8% to ₹557.20 in early trade on Tuesday, despite the company posting a strong turnaround in its Q4 FY25 earnings. The stock slipped as much as ₹22.20 from...
Aster DM Healthcare shares in focus today after Bengaluru expansion announcement
Aster DM Healthcare is in the spotlight today, May 7, after the company announced the signing of a 30-year lease agreement to establish a new multi-specialty hospital on Sarjapur Road, Bengaluru. This...
Aster DM Healthcare to set up new 430-bed hospital in Bengaluru’s Sarjapur area
Aster DM Healthcare has announced the signing of a lease agreement to establish a new multi-specialty hospital in Bengaluru. The facility will be located on Sarjapur Road, a rapidly developing localit...
Aster DM Healthcare gets Rs 1.08 crore GST demand notice from Bengaluru tax authorities
Aster DM Healthcare Ltd has received a demand order from the Joint Commissioner of Central Tax, GST Commissionerate, Bengaluru East, regarding the taxation of Covid-19 vaccination services. The order,...
HDFC Small Cap Fund sees 70.02% returns over 3 years, top holdings in Firstsource Solutions and Aster DM Healthcare
HDFC Small Cap Fund Direct-Growth is an equity mutual fund scheme offered by HDFC Mutual Fund. As of February 15, 2025, the scheme has an Asset Under Management (AUM) of ₹31,230.11 Crores, with a decl...
Aster DM Healthcare Transcript: Q3 24/25
Strong revenue and EBITDA growth continued in FY25, driven by operational efficiencies, capacity expansion, and a strategic merger with QCIL. Margins and ROCE improved, with robust cash flows supporting expansion and dividends. Regulatory approvals for the merger are pending.